SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CASTELLAZZI, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.665
EU - Europa 2.366
AS - Asia 1.502
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 14
Totale 11.565
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.658
CN - Cina 847
IT - Italia 498
UA - Ucraina 493
PL - Polonia 411
TR - Turchia 329
DE - Germania 297
GB - Regno Unito 246
SG - Singapore 205
SE - Svezia 128
FI - Finlandia 122
AT - Austria 46
CZ - Repubblica Ceca 34
FR - Francia 29
HK - Hong Kong 28
ID - Indonesia 25
BE - Belgio 23
VN - Vietnam 21
IR - Iran 19
AU - Australia 17
NL - Olanda 9
A2 - ???statistics.table.value.countryCode.A2??? 8
IN - India 8
KR - Corea 8
EU - Europa 6
CA - Canada 5
IQ - Iraq 5
PT - Portogallo 5
RO - Romania 5
ES - Italia 4
IE - Irlanda 3
JP - Giappone 3
HU - Ungheria 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RU - Federazione Russa 1
SV - El Salvador 1
TW - Taiwan 1
Totale 11.565
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.121
Fairfield 905
Chandler 713
Houston 578
Ashburn 563
Jacksonville 560
Warsaw 399
Ann Arbor 391
Wilmington 328
Seattle 317
Cambridge 294
Izmir 223
Ferrara 199
Nanjing 186
Beijing 155
Princeton 153
Singapore 127
Milan 118
New York 108
Boardman 107
San Diego 87
Shanghai 87
Dearborn 77
Addison 65
Los Angeles 57
Nanchang 55
Bremen 47
Shenyang 47
Vienna 45
Tianjin 44
Hebei 42
Jiaxing 42
Changsha 39
Norwalk 37
Brno 29
Hong Kong 28
Falls Church 26
Jakarta 25
Brussels 23
Redwood City 22
San Mateo 21
Dong Ket 20
Auburn Hills 19
Jinan 19
Ningbo 19
Orange 19
Mountain View 17
Washington 16
Zhengzhou 16
Bologna 14
London 14
Guangzhou 13
Kunming 12
Des Moines 11
Tappahannock 11
Indiana 10
Ferrara di Monte Baldo 9
Kraków 9
Verona 9
Leawood 8
Padova 8
Taizhou 8
Ardabil 7
Hefei 7
Munich 7
Philadelphia 7
Redmond 7
Changchun 6
Monmouth Junction 6
Rome 6
Hangzhou 5
Helsinki 5
Melbourne 5
Olomouc 5
Amsterdam 4
Andover 4
Augusta 4
Cagliari 4
Fuzhou 4
Haikou 4
Lanzhou 4
Yellow Springs 4
Berlin 3
Calderara Di Reno 3
Chicago 3
Hounslow 3
Kilburn 3
Reggio Emilia 3
Sant'elena 3
Serpa 3
Shaoxing 3
Clifton 2
Dolo 2
Dublin 2
Exeter 2
Forest City 2
Fremont 2
Győr 2
Harringay 2
Lamezia Terme 2
Totale 8.921
Salva come PNG Salva come JPEG
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 340
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 169
Epstein-Barr virus and Multiple Sclerosis: in-depth analysis of the virus-specific antibody response at the time of diagnosis and during therapy 167
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 150
Comparison of antibodies with amylase activity from cerebrospinal fluid and serum of patients with multiple sclerosis 146
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 140
A Commentary on the Use of Epstein-Barr Virus Specific Antibodies as Biological Markers in Multiple Sclerosis 136
Multiple Sclerosis in Italy: A 40-Year Follow-Up of the Prevalence in Ferrara 135
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 132
Autophagy and mitophagy elements are increased in body fluids of multiple sclerosis-affected individuals 132
Emerging topics and new perspectives on HLA-G 131
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 131
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 130
Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis 128
Cerebrospinal fluid analysis and the determination of oligoclonal bands 124
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 123
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 123
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker 122
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 121
Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis 118
Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis 118
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 117
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 114
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 114
Epidemiological health and social study on multiple sclerosis in the Ferrara province 114
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 114
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 112
null 110
null 109
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 108
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 106
Autophagy and mitophagy biomarkers are reduced in sera of patients with Alzheimer's disease and mild cognitive impairment 106
null 104
null 102
Intrathecal levels of vitamin D and IgG in multiple sclerosis 102
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 102
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 101
Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosis 100
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 99
Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms 98
null 97
null 97
null 96
Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage. 92
Neurofilament ELISA validation 90
null 90
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 89
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 89
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 88
null 88
null 87
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 87
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 86
Matrix Metalloproteinases as a Pleiotropic Biomarker in Medicine and Biology 86
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 86
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 85
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 85
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 85
null 84
null 84
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 82
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 82
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 81
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 81
An overview on the relationship between Epstein-Barr virus and multiple sclerosis 79
Intrathecal synthesis of interleukin-12 in multiple sclerosis 78
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 78
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 76
null 75
Inverse association between CSF levels of solubile HLA-G and Fas molecules in MS patients with no evidence of MRI disease activity. 74
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR THE IMPLEMENTATION A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES IN MS. 74
Biomolecular and immunological diagnostic aspects of toxoplasmosis during AIDS. 73
25 hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis during relapse and remission 72
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 71
25-hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis 70
Cerebrospinal fluid oligoclonal free light chain profiles in AIDS 69
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 68
null 68
Under the microscope: Focusing on Chlamydia pneumoniae infection and Multiple Sclerosis 67
N-acetylaspartate, glutammate and aspartate levels in multiple sclerosis cerebrospinal fluid. 67
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study. Int J Biomed Sci. 67
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study 67
null 66
null 66
Chlamydia pneumonia-specific CFS-restricted oligoclonal IgG bands are associated to a subset of patients with prosessive forms of multiple sclerosis. 65
Comparative analysis of environmental effects on multiple sclerosis development in Russian and Italian ethnic groups. 65
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 64
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 64
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 63
Cerebrospinal fluid free Kappa and Lambda lights chains in MS. A qualitative analysis 63
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 62
Le alterazioni liquorali nella neurosifilide sintomatica. 62
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 62
Potential role of soluble HLA-G molecules in multiple sclerosis 62
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 62
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 61
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 61
An evaluation of quantitative env and qualitative pol rt-pcr detection of the multiple sclerosis (MS) -associated retrovirus in Europe 60
Detection of serum soluble HLA-G levels in patients with acute ischemic stroke: a pilot study 60
Soluble HLA class I molecules intrathecal production in multiple sclerosis. 60
Totale 9.566
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 480
Totale 52.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.068 0 104 106 326 143 283 217 250 190 289 112 48
2020/20211.659 141 110 76 160 80 152 53 205 64 271 241 106
2021/20221.327 34 162 74 57 44 60 60 65 53 122 95 501
2022/20231.599 154 138 35 236 252 230 117 152 166 6 73 40
2023/2024956 79 88 45 25 101 187 27 85 35 25 28 231
2024/2025152 76 76 0 0 0 0 0 0 0 0 0 0
Totale 11.817